Abbott NJ, 1991, Control of brain endothelial permeability, Cerebrovasc. Brain Metab. Rev., 3, 39
10.1016/1357-4310(96)88720-X
10.1017/CBO9780511570216.038
10.1016/S0165-0173(97)00011-8
10.1016/S0361-9230(00)00230-6
10.1097/00002030-199818000-00006
Banks WA, 1999, Characterization of interleukin‐1α binding to mouse brain endothelial cells, J. Pharmacol. Exp. Therapeutics, 291, 665
10.1111/j.1471-4159.1980.tb04633.x
10.1016/0006-8993(95)00811-4
10.1113/jphysiol.1990.sp018243
10.1046/j.0953-816x.2001.01551.x
Chen Y, 2000, Endothelin‐1 and nitric oxide affect human cerebromicrovascular endothelial responses and signal transduction, Acta Neurochirurgica Suppl., 76, 131
Davson H, 1967, Transport in the central nervous system, Proc. Royal Soc. Med., 60, 326, 10.1177/003591576706000405
10.1111/j.1471-4159.1990.tb01236.x
Dolman DEM, 1998, Characterisation of a new in vitro model of the blood–brain barrier (BBB), J. Physiol., 505, 56
Easton AS, 1997, The effects of bradykinin on a cell culture model of the blood–brain barrier, J. Physiol., 505, 49
10.1111/j.1469-7793.1997.613bg.x
10.1002/(SICI)1097-4652(199606)167:3<451::AID-JCP9>3.0.CO;2-O
10.1016/S0304-3940(97)00679-4
10.1097/00005072-199011000-00001
10.1002/(SICI)1097-4652(199604)167:1<81::AID-JCP9>3.0.CO;2-8
10.1097/00006123-199909000-00010
Joó F, 1993, The Blood–Brain Barrier: Cellular and Molecular Biology, 267
10.1002/(SICI)1098-1136(199805)23:1<1::AID-GLIA1>3.0.CO;2-B
10.1002/9783906390437.ch9
10.1097/00001756-199904260-00035
10.1016/S0006-8993(99)01734-5
10.1126/science.283.5401.496
10.1523/JNEUROSCI.21-05-01538.2001
10.1016/S1385-299X(97)00008-1
10.1111/j.1476-5381.1995.tb15032.x
Olesen S‐P, 1989, An electrophysiological study of microvascular permeability and its modulation by chemical mediators, Acta Physiol. Scand., 136, 1
10.1097/00005344-200036051-00081
10.1016/S0304-3940(01)01904-8
10.1002/(SICI)1098-1136(199804)22:4<390::AID-GLIA8>3.0.CO;2-7
10.1046/j.1471-4159.1998.71020705.x
10.1016/S0887-2333(97)00039-8
10.1016/S0006-8993(97)00586-6
10.1111/j.1469-7793.2000.00177.x
10.1111/j.1469-7793.2000.00177.x
10.1016/S0014-5793(99)00451-2
Schulz J, 2000, LIF16‐0687 a novel non‐peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats, Acta Neurochirurgica Suppl., 76, 137
10.1046/j.1471-4159.1999.0731461.x
10.1016/S0168-0102(99)00079-6
10.1016/S0165-3806(97)00173-9
10.1016/S0361-9230(00)00368-3
10.1016/0006-8993(91)91628-E
10.1152/ajpcell.2000.279.2.C361
10.1016/S0304-3940(00)00987-3
10.1002/1098-1136(200011)32:2<155::AID-GLIA50>3.0.CO;2-4
10.1097/00004647-200006000-00009